Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China

Virus Research

Volumn 147, Issue 2, 2010, Pages 258-264

  Wang, Yun ^a   Liu, Xia ^a   Xing, Xiaoming ^a   Cui, Ying ^a   Zhao, Chengquan ^b   Luo, Bing ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Epstein Barr virus; Gastric carcinoma; Nasopharyngeal carcinoma; Nuclear antigen 1; Polymorphism

Indexed keywords

ALANINE; AMINO ACID; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; LEUCINE; PROLINE; THREONINE; VALINE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHINA; CONTROLLED STUDY; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; GENETIC LINKAGE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOMACH CARCINOMA; TUMOR BIOPSY; VIRUS CHARACTERIZATION; VIRUS STRAIN; VIRUS TYPING;

AMINO ACID SUBSTITUTION; CHINA; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS;

HUMAN HERPESVIRUS 4;

EID: 72949102427     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.11.010     Document Type: Article

References (55)

1. Adldinger H.K., Delius H., Freese U.K., Clarke J., and Bornkamm G.W. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141 (1985) 221-234
2. Akiba S., Koriyama C., Herrera-Goepfert R., and Eizuru Y. Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci. 99 (2008) 195-201
3. Ambinder R.F., Mullen M.A., Chang Y.N., Hayward G.S., and Hayward S.D. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 65 (1991) 1466-1478
4. Bell M.J., Brennan R., Miles J.J., Moss D.J., Burrows J.M., and Burrow S.R. Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response. J. Infect. Dis. 197 (2008) 1594-1597
5. Bhatia K., Raj A., Guitierrez M.I., Judde J.G., Spangler G., Venkatesh H., and Magrath I.T. Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13 (1996) 177-181
6. Bornkamm G.W. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Int. J. Cancer 124 (2009) 1745-1755
7. Chang C.M., Yu K.J., Mbulaiteye S.M., Hildesheim A., and Bhatia K. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res. 143 (2009) 209-221
8. Chang K.L., Chen Y.Y., Chen W.G., Hayashi K., Bacchi C., Bacchi M., and Weiss L.M. EBNA-1 gene sequences in Brazilian and American patients with Hodgkin's disease. Blood 94 (1999) 244-250
9. Chen M.R., Middeldorp J.M., and Hayward S.D. Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67 (1993) 4875-4885
10. Chen M.R., Tsai C.H., Wu F.F., Kan S.H., Yang C.S., and Chen J.Y. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines. J. Gen. Virol. 80 (1999) 447-455
11. Chen Y.Y., Chang K.L., Chen W.G., Shibata D., Hayashi K., and Weiss L.M. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma. Lab. Invest. 78 (1998) 877-882
12. Cheung S.T., Leung S.F., Lo K.W., Chiu K.W., Tam J.S., Fok T.F., Johnson P.J., Lee J.C., and Huang D.P. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int. J. Cancer 76 (1998) 399-406
13. Dawson C.W., Eliopoulos A.G., Blake S.M., Barker R., and Young L.S. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells. Virology 272 (2000) 204-217
14. Do N.V., Ingemar E., Phi P.T., Jenny A., Chinh T.T., Zeng Y., and Hu L. A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Res. 132 (2008) 15-24
15. Fassone L., Cingolani A., Martini M., Migliaretti G., Oreste P.L., Capello D., Gloghini A., Vivenza D., Dolcetti R., Carbone A., Antinori A., Gaidano G., and Larocca L.M. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma. AIDS Res. Hum. Retroviruses 18 (2002) 19-26
16. Fielding C.A., Sandvej K., Mehl A., Brennan P., Jones M., and Rowe M. Epstein-Barr virus LMP1-1 natural sequence variants differ in their potential to activate cellular signaling pathways. J. Virol. 75 (2001) 9129-9141
17. Görzer I., Niesters H.G., Cornelissen J.J., and Puchhammer-Stöckl E. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus Res. 118 (2006) 105-114
18. Gratama J.W., and Ernberg I. Molecular epidemiology of Epstein-Barr virus infection. Adv. Cancer Res. 67 (1995) 197-225
19. Greiner T.C., Abou-Elella A.A., Smir B.N., Orazi A., Hinrichs S., Anderson J., Gross T., Bierman P., and Hauke R. Molecular epidemiology of EBNA-1 substrains of Epstein-Barr virus in posttransplant lymphoproliferative disorders which have infrequent p53 mutations. Leuk. Lymphoma 38 (2000) 563-576
20. Gutiérrez M.I., Raj A., Spangler G., Sharma A., Hussain A., Judde J.G., Tsao S.W., Yuen P.W., Joab I., Magrath I.T., and Bhatia K. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J. Gen. Virol. 78 (1997) 1663-1670
21. Gutiérrez M.I., Spangler G., Kingma D., Raffeld M., Guerrero I., Misad O., Jaffe E.S., Magrath I.T., and Bhatia K. Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. Blood 92 (1998) 600-606
22. Habeshaw G., Yao Q.Y., Bell A.I., Morton D., and Rickinson A.B. Epstein-Barr virus nuclear antigen1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strain prevalent in different geographic areas. J. Virol. 73 (1999) 965-975
23. Ikuta K., Satoh Y., Hoshikawa Y., and Sairenji T. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect. 2 (2000) 115-120
24. Jeon Y.K., Lee B.Y., Kim J.E., Lee S.S., and Kim C.W. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea. Head Neck 26 (2004) 573-583
25. Kang M.S., Lu H., Yasui T., Sharpe A., Warren H., Cahir-McFarland E., Bronson R., Hung S.C., and Kieff E. Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 820-825
26. Kang M.S., Soni V., Bronson R., and Kieff E. Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice. J. Virol. 82 (2008) 4180-4183
27. Lee H.S., Chang M.S., Yang H.K., Lee B.L., and Kim W.H. Epstein-Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin. Cancer Res. 10 (2004) 1698-1705
28. Lee J.H., Kim S.H., Han S.H., An J.S., Lee E.S., and Kim Y.S. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J. Gastroenterol. Hepatol. 24 (2009) 354-365
29. Leight E.R., and Sugden B. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 10 (2000) 83-100
30. MacKenzie J., Gray D., Pinto-Paes R., Barrezueta L.F., Armstrong A.A., Alexander F.A., McGeoch D.J., and Jarrett R.F. Analysis of Epstein-Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brazil and the United Kingdom. J. Gen. Virol. 80 (1999) 2741-2745
31. Mai S.J., Ooka T., Li D.J., Zeng M.S., Jiang R.C., Yu X.J., Zhang R.H., Chen S.P., and Zeng Y.X. Functional advantage of NPC-related V-val subtype of Epstein-Barr virus nuclear antigen 1 compared with prototype in epithelial cell line. Oncol. Rep. 17 (2007) 141-146
32. Midgley R.S., Blake N.W., Yao Q.Y., Croom-Carter D., Cheung S.T., Leung S.F., Chan A.T., Johnson P.J., Huang D., Rickinson A.B., and Lee S.P. Novel intertypic recombinants of Epstein-Barr virus in the Chinese population. J. Virol. 74 (2000) 1544-1548
33. Niedobitek G. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol. Pathol. 53 (2000) 248-254
34. Puchhammer-Stöckl E., and Görzer I. Cytomegalovirus and Epstein-Barr virus subtypes-the search for clinical significance. J. Clin. Virol. 36 (2006) 239-248
35. Qiu K., Tomita Y., Hashimoto M., Ohsawa M., Kawano K., Wu D.M., and Aozasa K. Epstein-Barr virus in gastric carcinoma in Suzhou, China and Osaka, Japan: association with clinico-pathologic factors and HLA-subtype. Int. J. Cancer 71 (1997) 155-158
36. Rickinson A.B., Young L.S., and Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B cells. J. Virol. 61 (1987) 1310-1317
37. Sample J., Young L., Martin B., Chatman T., Kieff E., Rickinson A., and Kieff E. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64 (1990) 4084-4092
38. Sandvej K., Zhou X.G., and Hamilton-Dutoit S. EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: evidence for geographical polymorphism but not for tumour-specific subtype restriction. J. Pathol. 191 (2000) 127-131
39. Schuster V., Ott G., Seidenspinner S., and Kreth H.W. Limited sequence heterogeneity of Epstein-Barr virus nuclear antigen 1 in benign and malignant EBV-associated disorders. Infection 28 (2000) 137-142
40. Sidagis J., Ueno K., Tokunaga M., Ohyama M., and Eizuru Y. Molecular epidemiology of Epstein-Barr virus (EBV) in EBV-related malignancies. Int. J. Cancer 72 (1997) 72-76
41. Snudden D.K., Smith P.R., Lai D., Ng M.H., and Griffin B.E. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene 10 (1995) 1545-1552
42. Sugden B., and Warren N. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63 (1989) 2644-2649
43. Sugiura M., Imai S., Tokunaga M., Koizumi S., Uchizawa M., Okamoto K., and Osato T. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br. J. Cancer 74 (1996) 625-631
44. Thompson M.P., and Kurzrock R. Epstein-Barr virus and cancer. Clin. Cancer. Res. 10 (2004) 803-821
45. Uozaki H., and Fukayama M. Epstein-Barr virus and gastric carcinoma-viral carcinogenesis through epigenetic mechanisms. Int. J. Clin. Exp. Pathol. 1 (2008) 198-216
46. Wang J.T., Sheeng T.S., Su I.J., Chen J.Y., and Chen M.R. EBNA-1 sequence variations reflect active EBV replication and disease status or quiescent latency in lymphocytes. J. Med. Virol. 69 (2003) 417-425
47. Wang W.Y., Chien Y.C., Jan J.S., Chueh C.M., and Lin J.C. Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 8 (2002) 2586-2590
48. Wang Y., Luo B., Yan L.P., Huang B.H., and Zhao P. Relationship of Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis and apoptosis-related proteins in gastric carcinoma. World J. Gastroenterol. 11 (2005) 3234-3239
49. Wilson J.B., and Levine A.J. The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. Curr. Top. Microbiol. Immunol. 182 (1992) 375-384
50. Wilson J.B., Bell J.L., and Levine A.J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15 (1996) 3117-3126
51. Wrightham M.N., Stewart J.P., Janjua N.J., Pepper S.D., Sample C., Rooney C.M., and Arrand J.R. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208 (1995) 521-530
52. Wysokenski D.A., and Yates J.L. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol. 63 (1989) 2657-2666
53. Yates J.L., Warren N., and Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313 (1985) 812-815
54. Zeng M.S., Li D.J., Liu Q.L., Song L.B., Li M.Z., Zhang R.H., Yu X.J., Wang H.M., Ernberg I., and Zeng Y.X. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J. Virol. 79 (2005) 15323-15330
55. Zhang X.S., Wang H.H., Hu L.F., Li A., Zhang R.H., Mai H.Q., and Zeng Y.X. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett. 211 (2004) 11-18